TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Panel To Take Up Issues In Grant/Peer Review System, Consider NCAB Membership Requirements December 11, 1981
TCL Archive “NCI activities at Frederick are not well integrated…. It would be wise to reorganize and consolidate.” July 21, 1995
